Janssen Covid-19 vaccine eligible for approval
SEOUL: A South Korean panel of experts said Monday that vaccines for the novel coronavirus by Johnson & Johnson’s Janssen showed 66.9 per cent efficacy, paving the way for the authorisation of the country’s third Covid-19 vaccine, reported Yonhap. The advisory board consisting of outside experts announced its review on the efficacy and safety of […]
